Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-030615
Filing Date
2010-03-31
Accepted
2010-03-31 13:11:20
Documents
13
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c98548e10vk.htm 10-K 930377
2 EXHIBIT 4.5 c98548exv4w5.htm EX-4.5 45370
3 EXHIBIT 4.6 c98548exv4w6.htm EX-4.6 44818
4 EXHIBIT 4.8 c98548exv4w8.htm EX-4.8 23543
5 EXHIBIT 10.2 c98548exv10w2.htm EX-10.2 66469
6 EXHIBIT 10.11 c98548exv10w11.htm EX-10.11 57278
7 EXHIBIT 10.12 c98548exv10w12.htm EX-10.12 57319
8 EXHIBIT 21.1 c98548exv21w1.htm EX-21.1 1954
9 EXHIBIT 23.1 c98548exv23w1.htm EX-23.1 1439
10 EXHIBIT 31.1 c98548exv31w1.htm EX-31.1 5976
11 EXHIBIT 31.2 c98548exv31w2.htm EX-31.2 5991
12 EXHIBIT 32.1 c98548exv32w1.htm EX-32.1 3320
13 EXHIBIT 32.2 c98548exv32w2.htm EX-32.2 3342
  Complete submission text file 0000950123-10-030615.txt   1248944
Mailing Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111 415-283-2200
VIA Pharmaceuticals, Inc. (Filer) CIK: 0001003929 (see all company filings)

EIN.: 330687976 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27264 | Film No.: 10717713
SIC: 2836 Biological Products, (No Diagnostic Substances)